Search

Your search keyword '"Califf, RM"' showing total 1,550 results

Search Constraints

Start Over You searched for: Author "Califf, RM" Remove constraint Author: "Califf, RM"
1,550 results on '"Califf, RM"'

Search Results

1. Digitizing clinical trials

2. CTSA Consortium Consensus Scientific Review Committee (SRC) Working Group Report on the SRC Processes

3. Epifibatide is justified in community hospital treatment of ACS

4. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

7. Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes

12. Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes

14. Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

15. Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT trial

16. Discussion

17. Rivaroxaban compared with warfarin in patients with atrial fibrillation and prior stroke or transient ischaemic attack: a prespecified subgroup analysis of the ROCKET AF trial

21. Exploration of rapid bedside monitoring of coagulation and fibrinolysis parameters during thrombolytic therapy

22. Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction - Results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)

28. Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF

40. Comprehensive cardiovascular medicine

41. Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups

42. Selection of reperfusion therapy for individual patients with evolving myocardial infarction

45. High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin - Outcomes at 6 months and 1 year in the SYNERGY trial

46. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes

47. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: ameta-analysis of all major randomised clinical trials.

48. Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker

49. Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation - Incidence, predictors, and outcomes

50. Introduction

Catalog

Books, media, physical & digital resources